Scientists at the University of Basel have created a modular nanorobot capable of self-assembly, propulsion, and targeted delivery of payloads such as enzymes or drugs. The device consists of two reusable components—a propulsion module and a payload capsule—connected via a DNA-based 'molecular velcro' system. This allows the robot to autonomously assemble and function in environments like the human body. The payload capsule can be programmed to deliver therapeutic agents directly to specific cells, demonstrated in laboratory tests using human cancer cells. The technology has potential applications in medicine, industry, and environmental science.
Bias read (Center): The article discusses scientific innovation with no direct reference to politics, policy, or public figures. It focuses purely on technological development and does not present any ideological framing or bias.
Why these scores (Factual 85 · Objective 90): The article provides detailed technical descriptions of the nanorobot's design and functionality, citing the university and journal. No clear inaccuracies are present, though some details are speculative about future applications. The tone remains largely neutral and informative.




